We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.02B
AUM Growth
-$31.8M
(-0.79%)
Cap. Flow
-$14.7M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208
Avg Time Held Equity + Options
3.7
quarters
Top 10 Avg Time Held Equity + Options
1.3
quarters
Top 20 Avg Time Held Equity + Options
1.5
quarters
Avg Time Held Equity only
3.8
quarters
Top 10 Avg Time Held Equity only
1.3
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$191M |
| 2 |
Smartsheet Inc.
SMAR
|
+$188M |
| 3 |
Frontier Communications
FYBR
|
+$124M |
| 4 |
Summit Materials, Inc. Class A Common Stock
SUM
|
+$95M |
| 5 |
Altair Engineering Inc
ALTR
|
+$92.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CATALENT, INC.
CTLT
|
+$234M |
| 2 |
Marathon Oil Corporation
MRO
|
+$222M |
| 3 |
Stericycle Inc
SRCL
|
+$172M |
| 4 |
Axonics, Inc. Common Stock
AXNX
|
+$150M |
| 5 |
Perficient Inc
PRFT
|
+$79.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.76% |
| 2 | Energy | 15.79% |
| 3 | Communication Services | 7.77% |
| 4 | Consumer Staples | 7.72% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SPKL
251
DELISTED
Spark I Acquisition Corp
SPKL
| $711K | 0.02% |
66,832
| – | – |
2024 Q1
3 quarters
|
|
252
Connect Biopharma Holdings
CNTB
$54.8M
| $705K | 0.02% |
510,701
| – | – |
2022 Q2
10 quarters
|
|
253
Cullinan Oncology
CGEM
$999M
| $683K | 0.02% |
56,095
+10,120
| +22% | +$145K |
2023 Q2
6 quarters
|
|
254
DELISTED
ACELYRIN
SLRN
| $665K | 0.02% |
211,938
+48,214
| +29% | +$233K |
2023 Q4
4 quarters
|
|
255
Airbnb
ABNB
$97.8B
| $657K | 0.02% |
+5,000
| New | +$673K |
2024 Q4
0 quarters
|
|
256
DELISTED
Day One Biopharmaceuticals
DAWN
| $634K | 0.02% |
+50,020
| New | +$696K |
2024 Q4
0 quarters
|
|
257
Acrivon Therapeutics
ACRV
$81.8M
| $619K | 0.02% |
102,784
+23,535
| +30% | +$171K |
2023 Q2
6 quarters
|
|
258
DELISTED
Merus
MRUS
| $611K | 0.02% |
14,540
+4,618
| +47% | +$222K |
2022 Q1
11 quarters
|
|
259
ProQR Therapeutics
PRQR
$230M
| $602K | 0.02% |
+227,020
| New | +$721K |
2024 Q4
0 quarters
|
|
260
DELISTED
Mersana Therapeutics
MRSN
| $586K | 0.01% |
16,401
-6,400
| -28% | -$331K |
2023 Q3
5 quarters
|
|
261
Autodesk
ADSK
$49.2B
| $586K | 0.01% |
1,983
-3,017
| -60% | -$891K |
2024 Q3
1 quarter
|
|
262
Erasca
ERAS
$5.61B
| $576K | 0.01% |
229,600
+159,600
| +228% | +$438K |
2024 Q3
1 quarter
|
|
263
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $567K | 0.01% |
11,102
-3,998
| -26% | -$197K |
2024 Q3
1 quarter
|
|
264
PUT
Xerox
XRX
$361M
| $561K | 0.01% |
278,300
| – | – |
2021 Q2
14 quarters
|
|
265
DELISTED
Inozyme Pharma
INZY
| $557K | 0.01% |
201,232
-25,000
| -11% | -$95.1K |
2022 Q2
10 quarters
|
|
266
PUT
Viasat
VSAT
$9.92B
| $553K | 0.01% |
73,300
| – | – |
2024 Q2
2 quarters
|
|
267
Sutro Biopharma
STRO
$237M
| $553K | 0.01% |
30,062
-3,760
| -11% | -$115K |
2023 Q3
5 quarters
|
|
268
DELISTED
Third Harmonic Bio
THRD
| $553K | 0.01% |
53,740
+1,446
| +3% | +$18K |
2023 Q3
5 quarters
|
|
269
Marvell Technology
MRVL
$247B
| $552K | 0.01% |
5,000
-5,000
| -50% | -$464K |
2023 Q2
6 quarters
|
|
270
DELISTED
Ventyx Biosciences
VTYX
| $534K | 0.01% |
244,000
+44,000
| +22% | +$99.7K |
2024 Q3
1 quarter
|
|
271
Structure Therapeutics
GPCR
$1.82B
| $529K | 0.01% |
19,520
+1,520
| +8% | +$53.9K |
2024 Q3
1 quarter
|
|
272
Toyota
TM
$219B
| $525K | 0.01% |
+2,700
| New | +$475K |
2024 Q4
0 quarters
|
|
273
PUT
MGM Resorts International
MGM
$7.36B
| $524K | 0.01% |
125,000
| – | – |
2023 Q1
7 quarters
|
|
274
Asana
ASAN
$2.31B
| $507K | 0.01% |
25,000
| – | – |
2023 Q1
7 quarters
|
|
275
PUT
Herbalife
HLF
$1.37B
| $499K | 0.01% |
82,400
| – | – |
2024 Q1
3 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2024 Portfolio in Review
As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
UBS O'Connor's Q4 2024 filing shows 130 new, 130 increased, 70 reduced and 208 closed positions. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M. The largest sale was CATALENT, INC., an estimated $234M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.
- UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
- UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
- UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
- UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
- UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
- UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
- UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.
Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.